HAL-RAR Technique for Treating Hemorrhoids

NCT ID: NCT04778124

Last Updated: 2021-03-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2019-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A wide variety of methods has been proposed for treating hemorrhoidal disease with excisional hemorrhoidectomy remaining the gold standard. The aim of this trial is to assess the safety and effectiveness of the HAL-RAR technique in treating hemorrhoidal disease. Arterial ligation was performed by using the highest doppler signal to locate the site of the hemorrhoidal artery in combination with RAR in order to reposition redundant rectal mucosa/submucosa that prolapses to its original anatomical location, leading to resolution of symptoms.

This is a retrospective study from January 2010 to November 2019 of patients who underwent HAL-RAR for hemorrhoidal disease. Demographics, degree of disease, length of hospital stay, postoperative pain, complications (urinary retention, dyschezia, bleeding, necrosis of a hemorrhoid, anal discomfort, sensation of fullness) and recurrence were recorded. Patients were followed-up at postoperative day 1 and 8, and at 1, 6 and 12 months. The main outcome of the study was recurrence. Secondary outcomes included postoperative complications, postoperative pain and patient-assessed resolution of symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a retrospective, single-institution, study conducted from January 2010 to November 2019. Grade of hemorrhoidal disease was assessed according to Goligher's classification. Patients with grade II, resistant to conservative treatment, grade III and IV hemorrhoidal disease that underwent the HAL-RAR technique, were included in the study. Patients with grade II disease presented a small degree of prolapse. Non-surgical techniques, such as rubber-band ligation or injection of sclerosing agents, were not performed prior to the HAL-RAR operation since this is not a common practice in our institution. Conservative treatment for grade II hemorrhoids included diet rich in fiber, lifestyle modifications (increased fluid intake, improved anal hygiene, avoiding staining and constipation), the use of phlebotonics and other topical ointments that contained a combination of local anesthetics, corticosteroids and antiseptics, designed to relieve symptoms of pruritus and discomfort.

The study was reviewed and approved by the institution's ethics committee. Detailed informed consent was obtained from all patients before the operative procedure. Exclusion criterion included age \<18 years, pregnancy, coagulation disorders, patients with major comorbidities (American Society of Anesthesiologists \[ASA\] ≥3), psychiatric conditions preventing collaboration and follow-up, other concomitant anorectal disease (rectal prolapse, anal fissure, anal stenosis, perianal fistula or abscess, fecal incontinence) and previous pelvic radiotherapy. Preoperative clinical assessment and classification for all patients included complete medical history particularly underlining hemorrhoidal disease-related symptoms, physical examination, proctoscopy, and rigid sigmoidoscopy. Further investigation was performed when necessary.

Demographic data, degree of hemorrhoidal disease, length of hospital stay, perioperative and postoperative data were recorded. Clinical assessment and surgery were performed by two of the authors trained and experienced with the technique. Patients did not receive a solid diet after 10:00p.m. the night before surgery. Preoperative preparation included one or two phosphate enemas before the procedure. Antibiotic prophylaxis was not considered mandatory and was not administered. The severity of pain was self-evaluated by the patients using a visual analogue scale (VAS) with 0 indicating the absence of pain and 10 the worst possible pain. Data about analgesic consumption was also recorded. Postoperatively, intravenous Paracetamol 3gr and Parecoxid 80mg was administered daily, and in cases of severe pain Tramadol 500mg was given upon request. Patients were discharged when adequate pain control was achieved. They were examined by the surgeon to rule out early complications and ensure the outcome of the operation. Patients were advised to avoid prolonged straining and heavy physical activity for 1 month and to consume at least 2 liters of water per day and a diet rich in fiber, supplemented by the oral consumption of stool softeners. After discharge, oral analgesics were prescribed that consisted of nonsteroidal anti-inflammatory agents and oral narcotics. Patients were followed-up on postoperative day 1 and 8, and at 1, 6 and 12 months and evaluated with a proctologic examination. A patient directed diary card to assess the resolution of symptoms was implemented. Recurrence was evaluated after physical examination and defined as relapse of symptoms such as bleeding or prolapse often daily requiring manual reduction. The main outcome of the study was recurrence. Secondary outcomes included postoperative complications, postoperative pain and patient-assessed resolution of symptoms. Continuous variables are presented as median values and range, and categorical variables, as numbers and percentages.

Surgical technique The operation was performed, with the patient in the lithotomy position, under general or spinal anesthesia according to the patient's preference in consultation with the anesthesiologist. Perianal block was not offered as an alternative. The region is then treated with an antiseptic solution. After lubrication with xylocaine gel, the anal canal is dilated to a width of two fingers to allow insertion of the proctoscope. The HAL proctoscope, equipped with a doppler transducer (HAL II Doppler, A.M.I., Feldkirch, Austria) which is orientated just below the proctoscope's lateral ligation window, allows the identification and the selective ligation of the hemorrhoidal artery. In addition, a built-in light source provides illumination for easy placement of sutures under direct vision. As the submucosal terminal branches of the superior hemorrhoidal artery are best identified with the Doppler signal 2cm above the dentate line, the proctoscope was inserted 5-6 cm above the anal verge for best localization. The operation started and ended at the 12 o'clock position. The proctoscope was then rotated clockwise in search of the 6 main terminal branches, usually located at 1, 3, 5, 7, 9 and 11 o'clock. Once identified, the proctoscope was slowly withdrawn distally until the best Doppler signal was obtained. Arterial ligation was then performed with a "Z" suture using 2-0 polyglycolic acid and 5/8-inch needle. A knot-pusher was used to secure the suture. The lateral ligation window in the proctoscope's lumen was used to calculate the exact depth of the transfixed sutures. By inserting the tip of the needle holder inside the pivot hole before suturing, it ensured a maximum depth of 6mm, primarily involving the mucosa and submucosa, avoiding the perforation of the entire rectal wall. Eradication or significant reduction of the Doppler signal when tying the suture confirmed the successful arterial ligation. The proctoscope was rotated clockwise at the same level to locate further arteries. Once a full rotation had been completed, the procedure was repeated 15mm below the first series of sutures. The number of arterial ligations ranged from 6 to 10. After completion of the arterial ligation the RAR procedure, known as mucopexy, was performed where hemorrhoidal prolapse was detected. Using the same proctoscope, the outer sleeve is removed, in order to expand the operating window and expose a wider rectal mucosal area. The prolapsing tissue comes under direct vision inside the proctoscope's lumen. RAR is carried out with a continuous suture along the longitudinal axis in a proximal-to-distal direction in the lower part of the rectum with the same 2-0 polyglycolic acid and 5/8-inch needle. The continuous suture of the mucosa and submucosa can be performed repeatedly according to the size and extent of the prolapse and must always entrap the site of the hemorrhoidal artery with suture above and below. It is important to ensure 5mm distance between each suture, to avoid tissue ischemia and ensure sufficient venous outflow from the hemorrhoids. The continuous suture ends up to 1cm proximal to the dentate line, sparing the anal canal, avoiding postoperative pain. After securing the continuous suture the redundant rectal mucosa/submucosa that prolapses is repositioned to its original anatomical location. The number of RAR performed ranged from 1 to 5, while special attention was given to stay above the dentate line.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemorrhoidal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with hemorrhoidal disease undergoing HAL-RAR

This is a single-arm trial, in which all patients with grade II hemorrhoidal disease resistant to conservative treatment, grade III and IV hemorrhoidal disease underwent HAL RAR surgery.

Group Type OTHER

Hemorrhoidal Arterial Ligation (HAL) and Recto Anal Repair (RAR)

Intervention Type PROCEDURE

All patients underwent hemorrhoidal artery ligation on multiple sites according to pulsations detected by the doppler transducer and mucopexy (RAR) at the sites of prolapse.

Excision of thrombosed hemorrhoid / Hemorrhoidectomy /

Intervention Type PROCEDURE

One patient with mucosal necrosis of the hemorrhoidal cushion postoperatively underwent hemorrhoidectomy with excision of necrotic tissues.Furthermore, 2 patients who presented with hemorrhoidal thrombosis postoperatively underwent emergency surgery with supplementary excision of the thrombosed hemorrhoid. In addition, 9 patients who experienced recurrence of hemorrhoidal disease after undergoing HAL-RAR surgery, were treated with hemorrhoidectomy according to the Milligan-Morgan procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hemorrhoidal Arterial Ligation (HAL) and Recto Anal Repair (RAR)

All patients underwent hemorrhoidal artery ligation on multiple sites according to pulsations detected by the doppler transducer and mucopexy (RAR) at the sites of prolapse.

Intervention Type PROCEDURE

Excision of thrombosed hemorrhoid / Hemorrhoidectomy /

One patient with mucosal necrosis of the hemorrhoidal cushion postoperatively underwent hemorrhoidectomy with excision of necrotic tissues.Furthermore, 2 patients who presented with hemorrhoidal thrombosis postoperatively underwent emergency surgery with supplementary excision of the thrombosed hemorrhoid. In addition, 9 patients who experienced recurrence of hemorrhoidal disease after undergoing HAL-RAR surgery, were treated with hemorrhoidectomy according to the Milligan-Morgan procedure.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with

* grade II hemorrhoidal disease, resistant to conservative treatment
* grade III hemorrhoidal disease,
* grade IV hemorhoidal disease,

that underwent the HAL-RAR technique.

Exclusion Criteria

* pregnancy
* coagulation disorders
* patients with major comorbidities (American Society of Anesthesiologists \[ASA\] ≥3),
* psychiatric conditions preventing collaboration and follow-up
* other concomitant anorectal disease (rectal prolapse, anal fissure, anal stenosis, perianal fistula or abscess, fecal incontinence)
* previous pelvic radiotherapy
* declined consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sismanoglio - Amalia Fleming General Hospital

UNKNOWN

Sponsor Role collaborator

Amalia Fleming General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Georgia Dedemadi

MD, PhD, FACS

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georgia Dedemadi, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Amalia Fleming Hospital

References

Explore related publications, articles, or registry entries linked to this study.

Morinaga K, Hasuda K, Ikeda T. A novel therapy for internal hemorrhoids: ligation of the hemorrhoidal artery with a newly devised instrument (Moricorn) in conjunction with a Doppler flowmeter. Am J Gastroenterol. 1995 Apr;90(4):610-3.

Reference Type BACKGROUND
PMID: 7717320 (View on PubMed)

Ratto C, Campenni P, Papeo F, Donisi L, Litta F, Parello A. Transanal hemorrhoidal dearterialization (THD) for hemorrhoidal disease: a single-center study on 1000 consecutive cases and a review of the literature. Tech Coloproctol. 2017 Dec;21(12):953-962. doi: 10.1007/s10151-017-1726-5. Epub 2017 Nov 24.

Reference Type BACKGROUND
PMID: 29170839 (View on PubMed)

Popov V, Yonkov A, Arabadzhieva E, Zhivkov E, Bonev S, Bulanov D, Tasev V, Korukov G, Simonova L, Kandilarov N, Taseva A, Dimitrova V. Doppler-guided transanal hemorrhoidal dearterilization versus conventional hemorrhoidectomy for treatment of hemorrhoids - early and long-term postoperative results. BMC Surg. 2019 Jan 10;19(1):4. doi: 10.1186/s12893-019-0469-9.

Reference Type BACKGROUND
PMID: 30630463 (View on PubMed)

Aigner F, Gruber H, Conrad F, Eder J, Wedel T, Zelger B, Engelhardt V, Lametschwandtner A, Wienert V, Bohler U, Margreiter R, Fritsch H. Revised morphology and hemodynamics of the anorectal vascular plexus: impact on the course of hemorrhoidal disease. Int J Colorectal Dis. 2009 Jan;24(1):105-13. doi: 10.1007/s00384-008-0572-3. Epub 2008 Sep 3.

Reference Type BACKGROUND
PMID: 18766355 (View on PubMed)

Gallo G, Martellucci J, Sturiale A, Clerico G, Milito G, Marino F, Cocorullo G, Giordano P, Mistrangelo M, Trompetto M. Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease. Tech Coloproctol. 2020 Feb;24(2):145-164. doi: 10.1007/s10151-020-02149-1. Epub 2020 Jan 28.

Reference Type BACKGROUND
PMID: 31993837 (View on PubMed)

Emile SH, Elfeki H, Sakr A, Shalaby M. Transanal hemorrhoidal dearterialization (THD) versus stapled hemorrhoidopexy (SH) in treatment of internal hemorrhoids: a systematic review and meta-analysis of randomized clinical trials. Int J Colorectal Dis. 2019 Jan;34(1):1-11. doi: 10.1007/s00384-018-3187-3. Epub 2018 Nov 12.

Reference Type BACKGROUND
PMID: 30421308 (View on PubMed)

Karkalemis K, Chalkias PL, Kasouli A, Chatzaki E, Papanikolaou S, Dedemadi G. Safety and effectiveness of hemorrhoidal artery ligation using the HAL-RAR technique for hemorrhoidal disease. Langenbecks Arch Surg. 2021 Nov;406(7):2489-2495. doi: 10.1007/s00423-021-02190-0. Epub 2021 May 6.

Reference Type DERIVED
PMID: 33959805 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2042/4-3-2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hemorrhoid Radiofrequency
NCT06079892 RECRUITING